Treatment of cerebral cysticercosis with albendazole in elevated dosages-Reference-Cited by-同舟云学术

Treatment of cerebral cysticercosis with albendazole in elevated dosages

Published:2008-03 Issue:1 Volume:66 Page:114-116
ISSN:0004-282X
Container-title:Arquivos de Neuro-Psiquiatria
language:
Short-container-title:Arq. Neuro-Psiquiatr.

Author:

Rocha Jr Marco Antônio¹,Santos Juliana Machado Santiago dos²,Gomes Elisa Conci de Souza²,Rocha Marco Antônio³,Rocha Cristiane Franklin⁴,Carvalho Gervásio Teles Cardoso de⁵,Costa Bruno Silva⁶

Affiliation:

1. Faculdade de Ciências Médicas de Minas Gerais, Brazil; PUC/MG; SEMPER; Vera Cruz Hospitals, Brazil

2. Faculdade de Ciências Médicas de Minas Gerais, Brazil

3. Faculdade de Ciências Médicas de Minas Gerais, Brazil; SEMPER Hospital, Brazil

4. Faculdade de Ciências Médicas de Minas Gerais, Brazil; SEMPER

5. Faculdade de Ciências Médicas de Minas Gerais, Brazil; Santa Casa, Brazil

6. Santa Casa, Brazil

Publisher

FapUNIFESP (SciELO)

Subject

Neurology,Neurology (clinical)

Link

http://www.scielo.br/pdf/anp/v66n1/32.pdf

Reference9 articles.

1. Neurocisticercosis parenquimatosa activa: reporte de um caso y revisión de la literatura;Cerdas C;Rev Costorricense,2004

2. Fisiopatologia, diagnóstico e tratamento da cisticercose do sistema nervoso central: Temas atuais de neurocirurgia: cisticercose do SNC;Colli BO,2003

3. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind tiral;Singhi P;Pediatr Infect J,2003

4. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial;Kalra V;J Pediatr,2003

5. Severe forms of neurocysticercosis: treatment with albendazole;Agapejev S;Arq Neuropsiquiatr,1996

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subarachnoid Cysticercosis and Ischaemic Stroke in Epileptic Patients;Seizures;2018-05-02

2. Treatment-Resistant Human Extraparenchymal Neurocysticercosis: An Immune-Inflammatory Approach to Cysticidal Treatment Outcome;Neuroimmunomodulation;2018

3. Determining better treatments for neurocysticercosis;The Lancet Infectious Diseases;2014-08

4. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis;Expert Review of Clinical Pharmacology;2012-01

5. A simple LC-MS/MS method to determine plasma and cerebrospinal fluid levels of albendazole metabolites (albendazole sulfoxide and albendazole sulfone) in patients with neurocysticercosis;Biomedical Chromatography;2011-07-01